BILI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bilibili Inc. (BILI) is not a strong buy for a beginner, long-term investor at this moment. The stock has shown a significant decline in price (-4.87% in the regular market and -0.23% post-market), weak technical indicators, and a lack of positive trading signals. While analysts maintain a positive outlook with Buy and Overweight ratings, the company's financial performance shows concerning trends, including a sharp decline in net income and EPS. The upcoming earnings release could act as a catalyst, but the current setup does not present an optimal entry point for long-term investment.
The MACD is negative and expanding (-0.525), indicating bearish momentum. RSI is neutral at 38.232, and moving averages are converging, suggesting no clear trend. The stock is trading below the pivot point (31.998) and is approaching the S1 support level (29.657), which could act as a short-term floor.
The upcoming earnings release on March 5, 2026, could provide further insights.
Net income dropped significantly (-691.37% YoY), and EPS declined by -642.11% YoY. The stock has a 60% chance of declining further in the next day (-0.86%), week (-2.08%), and month (-4.97%). No significant hedge fund or insider trading activity, and no recent congressional trading data is available.
In Q3 2025, revenue increased by 5.20% YoY to 7.69 billion, but net income dropped sharply by -691.37% YoY to 470.23 million. EPS also fell significantly by -642.11% YoY to 1.03. Gross margin improved slightly by 5.16% YoY to 36.67.
BofA lowered its price target to $31 from $32 while maintaining a Buy rating. JPMorgan raised its price target to $27 from $24 with an Overweight rating. Analysts remain cautiously optimistic but have adjusted expectations for FY25-27 due to lower ad revenue projections.
